Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2024)
Historic Retained Earnings for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to -$13843.6 billion.
- Universe Pharmaceuticals' Retained Earnings fell 3610.12% to -$13843.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$13843.6 billion, marking a year-over-year decrease of 3610.12%. This contributed to the annual value of -$13843.6 billion for FY2025, which is 3610.12% down from last year.
- Universe Pharmaceuticals' Retained Earnings amounted to -$13843.6 billion in Q3 2025, which was down 3610.12% from -$10171.6 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Retained Earnings' 5-year high stood at $26.8 million during Q1 2022, with a 5-year trough of -$13843.6 billion in Q3 2025.
- Moreover, its 5-year median value for Retained Earnings was $6.6 million (2023), whereas its average is -$3001.9 billion.
- In the last 5 years, Universe Pharmaceuticals' Retained Earnings tumbled by 3486.41% in 2022 and then tumbled by 42877472885.37% in 2024.
- Universe Pharmaceuticals' Retained Earnings (Quarter) stood at $25.1 million in 2021, then tumbled by 34.86% to $16.3 million in 2022, then plummeted by 114.53% to -$2.4 million in 2023, then plummeted by 428774728.85% to -$10171.6 billion in 2024, then tumbled by 36.1% to -$13843.6 billion in 2025.
- Its Retained Earnings stands at -$13843.6 billion for Q3 2025, versus -$10171.6 billion for Q3 2024 and -$2.9 million for Q1 2024.